NetworkNewsBreaks – Avricore Health Inc.’s (TS
Post# of 61
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) today announced that its wholly owned subsidiary, HealthTab(TM), has entered into a non-exclusive, pilot supplier distribution agreement in Canada with Abbott, the global health care company, with respect to the handheld blood chemistry analyzer, i-STAT Alinity. Under the agreement, HealthTab will distribute Abbott’s point-of-care i-STAT Alinity and its associated tests for creatinine in Canadian pharmacies to better support patients with important information about their renal function. “Understanding renal function in patients at risk from or already living with chronic disease is critical,” said Hector Bremner, CEO of Avricore Health. “With i-STAT Alinity and its associated test for creatinine, health care professionals can obtain results in approximately two minutes to detect elevated levels of creatinine that are associated with abnormal renal function.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer